Inhibitor Therapeutics (INTI) Share-based Compensation (2013 - 2025)
Inhibitor Therapeutics' Share-based Compensation came in at $23,385 for FY2025, down 41.9% from $40,250 in FY2024.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Share-based Compensation (2013 - 2025) Analysis & Trends
Going back to FY2014, Inhibitor Therapeutics' Share-based Compensation data covers 11 years.
- Share-based Compensation carries a five-year compound annual growth rate of -36.6% (FY2020 to FY2025).
- The five-year range for annual Share-based Compensation is $13,784 (FY2023) to $40,250 (FY2024).
- Per Business Quant, earlier years put Share-based Compensation at $40,250 in FY2024 (+192.0%), $13,784 in FY2023 and $37,990 in FY2021 (-83.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Inhibitor Therapeutics | 13.90 Mn | 6.72 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 8,385.00 |
| Jun 30, 2024 | 1,160.00 |
| Mar 31, 2024 | 18,090.00 |
| Sep 30, 2023 | 1,534.00 |
| Mar 31, 2021 | 37,990.00 |
| Dec 31, 2020 | 119,336.00 |
| Sep 30, 2020 | 49,953.00 |
| Jun 30, 2020 | 42,753.00 |
| Mar 31, 2020 | 16,819.00 |
| Dec 31, 2019 | 30,162.00 |
| Sep 30, 2019 | 27,117.00 |
| Jun 30, 2019 | 81,614.00 |
| Mar 31, 2019 | 131,031.00 |
| Dec 31, 2018 | 125,451.00 |
| Sep 30, 2018 | 125,451.00 |
| Jun 30, 2018 | 83,953.00 |
| Mar 31, 2018 | 208,243.00 |
| Dec 31, 2017 | 14,060.00 |
| Sep 30, 2017 | 14,064.00 |
| Jun 30, 2017 | 9,376.00 |
API Access
Inhibitor Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();